Mirae Asset Global Investments’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.5K | Buy |
11,530
+1,601
| +16% | +$5.49K | ﹤0.01% | 1294 |
|
|
2025
Q1 | $22.9K | Buy |
9,929
+86
| +0.9% | +$199 | ﹤0.01% | 1374 |
|
|
2024
Q4 | $29.4K | Sell |
9,843
-814
| -8% | -$2.43K | ﹤0.01% | 1363 |
|
|
2024
Q3 | $27.8K | Buy |
10,657
+1,878
| +21% | +$4.9K | ﹤0.01% | 1389 |
|
|
2024
Q2 | $25.3K | Sell |
8,779
-91,366
| -91% | -$263K | ﹤0.01% | 1350 |
|
|
2024
Q1 | $730K | Buy |
+100,145
| New | +$730K | ﹤0.01% | 1706 |
|
|
2023
Q2 | – | Sell |
-98,550
| Closed | -$743K | – | 2604 |
|
|
2023
Q1 | $743K | Sell |
98,550
-144
| -0.1% | -$1.09K | ﹤0.01% | 1699 |
|
|
2022
Q4 | $1,000K | Buy |
98,694
+5,819
| +6% | +$58.9K | ﹤0.01% | 1495 |
|
|
2022
Q3 | $918K | Buy |
92,875
+26,379
| +40% | +$261K | ﹤0.01% | 1528 |
|
|
2022
Q2 | $708K | Buy |
+66,496
| New | +$708K | ﹤0.01% | 1583 |
|